Skip to content

CHUGAI PHARMACEUTICAL LTD

Active Risk: not assessed
Foreign entityfounded 2018active for 8 yearsUKIMA 5 -CHOME 5-1, 115-8543 KITA - KU TOKYO, JapanKBO/BCE: BE 0693.986.401
Summary

CHUGAI PHARMACEUTICAL LTD has the legal form “Foreign entity” in the KBO; Checked does not compute a bankruptcy probability for it. The company has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank.

CHUGAI PHARMACEUTICAL LTDActive

Overview

Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE 21100
Size
No accounts filed yet
Financial health
No score: no figuresBankruptcy probability: legal form outside the model
Structure
No directors known

Key points

  • Caution: No annual accounts yetat the National Bank 0 filed View
  • Active since 2018founded 01-01-2018 8 years View

By topic

Company details

Legal form
Foreign entity
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21100
Founded
01-01-2018
Peppol
Not found in the Peppol directory
Go to Company details

Key facts about CHUGAI PHARMACEUTICAL LTD

What is the company number of CHUGAI PHARMACEUTICAL LTD?
0693.986.401. In Belgium the VAT number is the company number with BE in front: BE 0693.986.401.
Where is CHUGAI PHARMACEUTICAL LTD based?
The registered office is at UKIMA 5 -CHOME 5-1, 115-8543 KITA - KU TOKYO.Company details
What does CHUGAI PHARMACEUTICAL LTD do?
According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21100).
What is the legal form of CHUGAI PHARMACEUTICAL LTD?
Foreign entity.
When was CHUGAI PHARMACEUTICAL LTD founded?
On 01-01-2018.
Is CHUGAI PHARMACEUTICAL LTD still active?
Yes, CHUGAI PHARMACEUTICAL LTD is an active enterprise in the KBO register.

Companies related to CHUGAI PHARMACEUTICAL LTD

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.